BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 294470)

  • 21. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H; Anadere I; Heimburg P
    Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study on the effect of pentoxifylline on blood rheology and microcirculation--a study using an endotoxin shock model].
    Sugiura Y; Kato T; Goto Y; Yamamoto K; Aochi O
    Masui; 1983 Apr; 32(4):435-41. PubMed ID: 6887508
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension].
    Winkler R; Moser M
    Wien Klin Wochenschr; 1983 Mar; 95(6):209-13. PubMed ID: 6880203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy for peripheral arterial disease.
    Naide D
    Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
    [No Abstract]   [Full Text] [Related]  

  • 28. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
    Koshkin VM; Adil'khanov SG; Antonova NIu
    Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 32. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience.
    Küchle HJ; Richard G
    Ric Clin Lab; 1981; 11 Suppl 1():333-43. PubMed ID: 7188121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy].
    Perego MA; Sergio G; Artale F
    Ric Clin Lab; 1981; 11 Suppl 1():281-91. PubMed ID: 7188115
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
    Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D
    Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.